Picture EBD Group BIO-Europe 2021 Digital BEU2021 650x80
Document › Details

Pherecydes Pharma S.A.. (1/29/21). "Press Release: Pherecydes Pharma Brings Forward the Closing of Its IPO to February 1, 2021, Given Its Strong Success With Investors [Not for US, CA, AU or JP]". Nantes.

Region Region France
Organisations Organisation Pherecydes Pharma S.A. (Euronext Paris: ALPHE)
  Organisation 2 NewCap. – Investor Relations & Financial Communications
Products Product antibiotic
  Product 2 investment banking
Index term Index term Pherecydes Pharma–SEVERAL: investment, 202102 IPO €8m with 1.334m new shares incl full over-allotment at €6/share at Euronext Growth Paris
Persons Person Rousseau, Philippe (Pherecydes Pharma 202101 CFO formerly ExonHit 200801–200906 CFO)
  Person 2 Merigeau, Nicolas (NewCap 201502)

Record changed: 2021-09-07


Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Pherecydes Pharma S.A. (Euronext Paris: ALPHE)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture [iito] Back into Ad 650x80px

» top